| Endo II | CRC ITT discovery set | CRC ITT validation set | ||
---|---|---|---|---|---|
All | Control | Disease | Control | Disease | |
Total | 4698 | 2759 | 340 | 1189 | 147 |
Clinic number: # | |||||
31 | 605 | 340 | 53 | 135 | 26 |
32 | 299 | 171 | 13 | 81 | 9 |
33 | 966 | 579 | 71 | 249 | 21 |
34 | 300 | 190 | 18 | 65 | 12 |
35 | 957 | 564 | 72 | 240 | 34 |
36 | 858 | 510 | 48 | 248 | 17 |
37 | 713 | 405 | 65 | 171 | 28 |
Age: years | |||||
Mean | 63.5 | 62.7 | 69.7 | 62.9 | 70.1 |
Standard deviation | 12.6 | 12.6 | 10.6 | 12.7 | 10.7 |
Median | 64.3 | 63.6 | 69.5 | 63.3 | 71.5 |
Minimum | 18.1 | 20.1 | 37.5 | 18.1 | 23.6 |
Maximum | 96.0 | 96.0 | 94.8 | 93.3 | 89.1 |
Gender: # (%) | |||||
Female | 2455 (52.3) | 1473 (53.4) | 144 (42.4) | 650 (54.7) | 55 (37.4) |
Male | 2243 (47.7) | 1286 (46.6) | 196 (57.6) | 539 (45.3) | 92 (62.6) |
BMI: kg/m 2 | |||||
Mean | 25.6 | 25.6 | 25.5 | 25.5 | 26.2 |
Standard deviation | 4.6 | 4.7 | 4.7 | 4.5 | 3.9 |
Median | 25.1 | 25.1 | 24.8 | 25.0 | 25.7 |
Minimum | 11.7 | 13.0 | 15.8 | 11.7 | 16.9 |
Maximum | 50.5 | 50.2 | 47.1 | 50.5 | 39.1 |
CRC stage: # (%) | |||||
I | 101 (19.8) | 0 (0) | 74 (21.8) | 0 (0) | 25 (17.0) |
II | 163 (31.9) | 0 (0) | 105 (31.0) | 0 (0) | 50 (34.0) |
III | 139 (27.2) | 0 (0) | 87 (25.7) | 0 (0) | 45 (30.6) |
IV | 108 (21.1) | 0 (0) | 73 (21.5) | 0 (0) | 27 (18.4) |
Diagnosis: # (%) | |||||
Colon cancer | 319 (6.8) | 0 (0) | 211 (62.1) | 0 (0) | 92 (62.6) |
Rectal cancer | 193 (4.1) | 0 (0) | 129 (37.9) | 0 (0) | 55 (37.4) |
Adenoma colon | 515 (11.0) | 340 (12.3) | 0 (0) | 148 (12.4) | 0 (0) |
Adenoma rectum | 174 (3.7) | 117 (4.2) | 0 (0) | 51 (4.3) | 0 (0) |
No comorbidity-no finding | 1164 (24.8) | 763 (27.7) | 0 (0) | 334 (28.1) | 0 (0) |
Comorbidity-no finding | 814 (17.3) | 534 (19.4) | 0 (0) | 229 (19.3) | 0 (0) |
Other cancer | 177 (3.8) | 119 (4.3) | 0 (0) | 50 (4.2) | 0 (0) |
Other finding | 1342 (28.6) | 886 (32.1) | 0 (0) | 377 (31.7) | 0 (0) |